ATE128355T1 - Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika. - Google Patents

Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.

Info

Publication number
ATE128355T1
ATE128355T1 AT88904126T AT88904126T ATE128355T1 AT E128355 T1 ATE128355 T1 AT E128355T1 AT 88904126 T AT88904126 T AT 88904126T AT 88904126 T AT88904126 T AT 88904126T AT E128355 T1 ATE128355 T1 AT E128355T1
Authority
AT
Austria
Prior art keywords
cough
sedating
cold
anthistaminics
mixtures containing
Prior art date
Application number
AT88904126T
Other languages
English (en)
Inventor
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Original Assignee
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21920155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE128355(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abraham Sunshine, Eugene M Laska, Carole E Siegel filed Critical Abraham Sunshine
Application granted granted Critical
Publication of ATE128355T1 publication Critical patent/ATE128355T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AT88904126T 1987-04-24 1988-04-22 Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika. ATE128355T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/042,120 US4783465A (en) 1984-04-09 1987-04-24 Cough/cold mixtures comprising non-sedating antihistamine drugs

Publications (1)

Publication Number Publication Date
ATE128355T1 true ATE128355T1 (de) 1995-10-15

Family

ID=21920155

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904126T ATE128355T1 (de) 1987-04-24 1988-04-22 Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.

Country Status (9)

Country Link
US (1) US4783465A (de)
EP (1) EP0311677B1 (de)
JP (1) JPH01503539A (de)
AT (1) ATE128355T1 (de)
AU (1) AU610178B2 (de)
CA (1) CA1327315C (de)
DE (1) DE3854518T2 (de)
WO (1) WO1988008302A1 (de)
ZA (1) ZA882884B (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643187B2 (en) * 1984-04-09 1993-11-11 Eugene M. Laska Cough-cold mixtures comprising non-steroidal anti-inflammatory drugs
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US4933172A (en) * 1988-10-06 1990-06-12 Warner-Lambert Co. Method of and compositions for treating destructive periodontal disease
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
AU8505991A (en) * 1990-09-11 1992-03-30 Richardson-Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
JPH06502166A (ja) * 1990-09-28 1994-03-10 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−抗ヒスタミン薬の組み合わせ
EP0574424A1 (de) * 1991-03-04 1993-12-22 Warner-Lambert Company Salz/ionpaare von nicht-steroiden enzündungshemmenden arzneimitteln in verschiedenen dosierungsformen
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
JPH06506684A (ja) * 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
DE69426306T2 (de) * 1993-10-25 2001-06-07 Merrell Pharma Inc Stabile pharmazeutische zubereitungen, die terfenadine und ibuprofen enthalten
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
US5906747A (en) * 1995-11-13 1999-05-25 Biosepra Inc. Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
US6060060A (en) * 1997-01-31 2000-05-09 Bmb Patent Holding Corporation Analgesic compositions from sweet peppers and methods of use thereof
GB2324242A (en) * 1997-04-18 1998-10-21 Atindra Nath Chakrabarty Medicaments for treating viral infections
WO1998052566A1 (en) * 1997-05-21 1998-11-26 Warner-Lambert Company Non-sedating acrivastine preparation
WO1999015173A1 (en) * 1997-09-19 1999-04-01 The Procter & Gamble Company Compositions and methods for treating respiratory disorders
IN188720B (de) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6086888A (en) * 1998-12-22 2000-07-11 Bmb Patent Holding Corporation Analgesic compositions from sweet bell peppers and methods of use thereof
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
BR0003648A (pt) * 2000-03-30 2002-01-02 Schering Corp Composições e métodos para tratar condições alérgicas e inflamatórias com tosse
US20030216423A1 (en) * 2000-05-24 2003-11-20 Sergio Ulloa Stable liquid and solid formulations
PA8517201A1 (es) * 2000-05-25 2002-08-26 Schering Corp Composiciones farmaceuticas antihistaminicas anticongestivas liquidas estables
US6440983B1 (en) * 2000-12-21 2002-08-27 Mary Theresa Frank-Kollman Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
KR20090029314A (ko) 2001-06-28 2009-03-20 유씨비 파쉼 소시에떼아노님 세티리진 및 슈도에페드린을 포함하는 정제
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
CZ292874B6 (cs) * 2002-01-30 2003-12-17 Léčiva, A. S. Farmaceutický prostředek k ošetření akutních bolestí
JP4614638B2 (ja) * 2002-06-07 2011-01-19 第一三共株式会社 鎮痛剤組成物
JP4614640B2 (ja) * 2002-07-04 2011-01-19 第一三共株式会社 解熱剤組成物
JP2010159299A (ja) * 2002-07-04 2010-07-22 Daiichi Sankyo Co Ltd ロキソプロフェンとケトチフェンを含有する解熱剤組成物
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
EP2240018B1 (de) 2008-01-04 2016-05-25 Schabar Research Associates LLC Zusammensetzung enthaltend ein analgetikum und ein antihistaminikum
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
US10046052B2 (en) * 2010-05-14 2018-08-14 Bernard Silverman Method and formulation for cold treatment in adults and children with increased safety
EP2985036A3 (de) 2014-08-14 2016-03-09 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. CYP2J2-Antagonisten zur Behandlung von Schmerzen
US11219629B2 (en) 2019-10-17 2022-01-11 Hooman M. MELAMED Anesthetic pharmaceutical composition, system and method
IL299845A (en) 2020-07-15 2023-03-01 Schabar Res Associates Llc Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
CA3199168A1 (en) 2020-12-04 2022-06-09 Laboratorios Silanes S.A. De C.V. Pharmaceutical composition of an analgaesic and an antihistamine forthe treatment of respiratory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy

Also Published As

Publication number Publication date
EP0311677B1 (de) 1995-09-27
DE3854518D1 (de) 1995-11-02
US4783465A (en) 1988-11-08
ZA882884B (en) 1988-10-27
WO1988008302A1 (en) 1988-11-03
AU1687388A (en) 1988-12-02
CA1327315C (en) 1994-03-01
AU610178B2 (en) 1991-05-16
DE3854518T2 (de) 1996-02-22
JPH01503539A (ja) 1989-11-30
EP0311677A1 (de) 1989-04-19

Similar Documents

Publication Publication Date Title
ATE128355T1 (de) Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.
US4552899B1 (de)
AU1948488A (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
DE69316023D1 (de) Stabile zusammensetzung für eine orale dosis mit verlängerter freisetzung
DK372786A (da) Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
ES2062355T3 (es) Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina.
MX9405219A (es) Nueva formulacion farmaceutica.
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
IT1208735B (it) Formulazioni farmaceutiche a basedi arecolina e simili,lore preparazione ed impiego nel trattamento di disturbi della memoria
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
NO983926L (no) Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer
CO5031291A1 (es) Composicion farmaceutica
NO993921L (no) Medikament mot infertilitet og for ökt fertilitet
DE69026295D1 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
ITMI921573A0 (it) Dispositivo di somministrazione di farmaci particolarmente per aerosolterapia e simili

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked